🥗 Nutrition · 11 min read · Subtopic 5 of 5

Who Should Not Do Keto

Most questions about ketogenic diets are about trade-offs. This page is about the people for whom they are a safety question first: those taking medicines that interact badly with ketosis, those with conditions that need assessment before starting, and those in life stages where the evidence points away from the diet entirely. It ends with the red flags that mean "get medical help now" — and the questions to ask a clinician first.

🔎 Evidence Snapshot ★★★☆☆ Moderate — regulatory warnings and clear mechanisms; rare-event frequency estimates are thin

What the evidence supports

  • SGLT2 inhibitors carry a regulatory warning for ketoacidosis at normal or only mildly elevated blood sugar, and a case series describes it developing when combined with a ketogenic diet.
  • In type 1 diabetes, ketone production without enough insulin is the classic route into diabetic ketoacidosis.
  • Several groups warrant a clinician's assessment before starting: pregnancy and breastfeeding, chronic kidney disease, eating-disorder history, pancreatitis, gallbladder disease, and anyone on glucose-lowering medication.
  • In children and adolescents, ketogenic diets are an established therapy for some drug-resistant epilepsies — inside specialist programs, not ordinary dieting.

What remains uncertain

  • How often the rare complications occur is not well quantified — the SGLT2 signal rests on case reports and warnings, which show events happen, not how often.
  • Pregnancy and breastfeeding have little direct safety study; guidance leans on caution.

Evidence last reviewed: October 7, 2026. Conclusions may change as new research is published.

A pharmacist speaks with a man across a pharmacy counter.
medications change the risk calculus

The Medication List Comes First

Start with the prescription list, not the menu: diet advice assumes no medications, and carbohydrate restriction breaks that assumption. SGLT2 inhibitors — empagliflozin, dapagliflozin, canagliflozin and their relatives — lower blood sugar through the kidneys, are prescribed for type 2 diabetes, heart, and kidney protection, and carry a regulatory warning for a specific failure mode: ketoacidosis at normal or only mildly elevated glucose — euglycemic DKA. The FDA warned in 2015; label warnings followed. Combined with a ketogenic diet, the risk stops being theoretical.

A case series in AACE Clinical Case Reports (Mistry & Eschler, 2021) described two patients who developed euglycemic DKA on this combination — one after a single empagliflozin dose, the other after about a week. The authors advise avoiding ketogenic diets on these medicines.

Beyond that pairing, anyone on glucose-lowering medication — insulin, sulfonylureas, others — faces an adjustment problem: fewer carbohydrates usually mean lower drug requirements. In the supervised programs with the strongest type 2 diabetes results, that adjustment was a clinical task built into the protocol (see the T2D reversal evidence page). The machinery underneath belongs to the insulin resistance topic.

Type 1 Diabetes and Insulin Deficiency

Type 1 diabetes is different: insulin production fails, and without enough insulin, the same ketone pathway that defines nutritional ketosis can tip into diabetic ketoacidosis. The ketosis page separates those states carefully — the separation matters most here.

Some people with type 1 diabetes do follow very-low-carbohydrate diets with specialist support; a self-selected survey of 316 adults and children (Lennerz et al., Pediatrics, 2018) reported a mean HbA1c of 5.7% with rare hospitalizations — numbers the authors say cannot establish long-term safety. Insulin doses, ketone monitoring, and sick-day rules are not self-service: talk with your diabetes team before anything changes.

Pregnancy, Breastfeeding, and Young People

Pregnancy raises the stakes on every nutrition choice: energy and micronutrient needs climb, and the best-studied eating patterns earned that status through decades of outcome data. Ketogenic diets are not among them — professional guidance does not endorse them in pregnancy, and direct safety data are scarce. The caution carries into breastfeeding; this is a period for established patterns and clinician discussions, not experiments.

Children and adolescents are a related case: ketogenic diets have a genuine pediatric role as supervised therapy for some drug-resistant epilepsies — the Cochrane review of that evidence (updated 2020) describes a program, not a diet. Outside that setting, growing bodies need breadth that strict carbohydrate limits squeeze out.

💊 Never adjust diabetes medication on your own

When carbohydrate intake drops, insulin requirements and sulfonylurea doses can change within days. Keeping the old doses can push blood sugar too low; cutting them without guidance can push it too high. Both directions can put a person in the hospital. The adjustment is a prescribing decision — it belongs to the clinician who knows your history.

Kidney Disease, Pancreatitis History, and Gallbladder Issues

Eating-Disorder History: A Different Kind of Risk

One group deserves its own section: the risk looks different. Ketogenic and very-low-carbohydrate diets are, structurally, sets of firm food rules — counting a macronutrient, excluding whole food groups, treating a meter reading as a verdict on whether you did well. For many people those rules are merely tedious; for someone with a history of restriction, bingeing, or obsessive tracking, they can feed the problem rather than fix it.

Disorder risk does not track body size — a lean person "doing great at keto" can be struggling — and only the person living it knows whether the rules are running their life. If food has ever taken over that way, raise it with a clinician or therapist before starting any strict pattern, and treat growing rigidity, guilt, or hiding behavior around food as a signal to stop and get support.

Who Needs What: The Supervision Spectrum

None of this is one-size-fits-all. The chart reads the tiers; the table maps the situations.

The Supervision Spectrum — a Reading Aid
Bar lengths are a qualitative tier assigned in this page's review, not a measured quantity. The dashed row marks its own rule: children and adolescents, where ketogenic diets belong in specialist programs.
SGLT2 inhibitors do not combine Type 1 diabetes specialist input Diabetes medication adjustment needed Pregnancy, breastfeeding discuss first Eating disorder history screen first Kidney disease pre-start check Children & adolescents — specialist programs (e.g., epilepsy care)
SituationWhy it mattersWhat to doRead
💊 SGLT2 inhibitor medicine Warning for ketoacidosis at normal glucose; reported with ketogenic diets Do not combine without specialist input Do not combine
🩸 Type 1 diabetes Insulin deficiency plus ketone production is the classic DKA setup Specialist management with monitoring Specialist-led
💉 Any glucose-lowering medication Fewer carbohydrates usually means lower drug requirements Adjustment comes from your prescriber Adjustment needed
🤰 Pregnancy or breastfeeding High nutrient demands; direct safety data are scarce Discuss with a prenatal clinician Discuss first
🫘 Chronic kidney disease Protein, potassium, and acid–base handling all shift Pre-start assessment with labs Assess first
🍽️ Eating-disorder history Restrictive food rules can feed harmful patterns Screening and support before starting Screen first
🎗️ Pancreatitis history Review when the original cause was never settled Clinician review first Review first
🫓 Gallbladder disease Rapid weight loss of any kind associates with gallstone trouble Discuss before starting Discuss first
🧒 Children & adolescents Specialist programs such as epilepsy care Not a self-start decision Specialist-led
2 cases
Euglycemic DKA cases in the SGLT2-plus-keto case series — both while combining the medicine with carbohydrate restriction
1 dose
Empagliflozin exposure before one reported case — prolonged overlap was not required
2015
Year the FDA warned that SGLT2 inhibitors can cause ketoacidosis at normal blood sugar

Red Flags That Are Not "Keto Flu"

Early fatigue and headache on low-carb starts are usually transient. The symptoms below suggest a metabolic emergency — especially for anyone near the medicine and condition lists above.

Seek urgent medical care for any of these rather than troubleshooting macros: ketoacidosis is treatable when caught early, dangerous when not.

Questions to Ask Your Clinician

If you want the conversation rather than a gamble, make it specific:

None of this is a verdict on ketogenic diets for the people they suit — the rest of the series, under the Keto & Very-Low-Carb parent topic, makes the affirmative case where it exists and audits the hype where it does not, on the longevity claims page. The point here is narrower: for some people the risks are real, and the decisions belong with a professional.

⚠️ Medical caution: Educational content only — not medical advice. Ketogenic diets require clinician supervision in type 2 diabetes (medication adjustment), and are unsuitable for some people, including those on SGLT2 inhibitors, during pregnancy, or with kidney disease or an eating-disorder history. Discuss any major diet change with a qualified professional.

The Bottom Line

  1. The medication list is the first check — SGLT2 inhibitors are the clearest do-not-combine pairing, and diabetes medication adjustments belong to the prescriber.
  2. Type 1 diabetes is specialist territory — ketones without enough insulin are the route to an emergency, and insulin plans are not self-adjustable.
  3. Several conditions and life stages need pre-start advice — pregnancy, breastfeeding, kidney disease, eating-disorder history, pancreatitis, gallbladder disease, and children outside specialist programs.
  4. Red flags override everything — persistent vomiting, abdominal pain, rapid breathing, confusion, or thirst with malaise mean urgent care; a normal glucose reading does not rule ketoacidosis out.

Related Topics

Sources & further reading